pULMONARY MUCOEPIDERMOID CARCINOMA: DIAGNOSIS

Ali, Syed Aamir; Jamshed, Arif; Khattak, Shahid; Sultan, Faisal; Yousaf, Muhammad; Siddiqui, Neelam; Loya, Asif; Jahanzeb, Mohammad; Muhammad Abdur Rafaye; Sadaf Usman; Arif Jamshed

doi:10.37029/jcas.v3i1.111

USE OF SIMULTANEOUS INTEGRATED BOOST INTENSITY-MODULATED RADIATION THERAPY TECHNOLOGY IN LARYNGEAL CARCINOMA

Muhammad Abdur Rafaye Shaukat Khanum Memorial Cancer Hospital & Research Centre Lahore Pakistan
Sadaf Usman Shaukat Khanum Memorial Cancer Hospital & Research Centre Lahore Pakistan
Arif Jamshed Shaukat Khanum Memorial Cancer Hospital & Research Centre Lahore Pakistan

DOI: https://doi.org/10.37029/jcas.v3i1.111

Abstract

References

Deodato F, Cilla S, Macchia G, et al. IMRT/VMATSIB technique chemoradiation in locally advanced head and neck cancer: Toxicity results. Radiother Oncol 2016;119:S501-2.

Pyakuryal A, Pandit S, Narayanasamy G, et al. Radiobiologic evaluation of simultaneously integrated boost (SIB) IMRT methods in head and neck cancer: Multi-institutional study. Int J Radiat Oncol Biol Phys 2014;90:S789-90.

Leclerc M, Maingon P, Hamoir M, et al. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach. Radiother

Oncol 2013;106:333-40.

Published

2017-04-01

How to Cite

Rafaye MA, Usman S, Jamshed A. USE OF SIMULTANEOUS INTEGRATED BOOST INTENSITY-MODULATED RADIATION THERAPY TECHNOLOGY IN LARYNGEAL CARCINOMA. J Cancer Allied Spec [Internet]. 2017Apr.1 [cited 2024Nov.25];3(1). Available from: https://jcas.journals.publicknowledgeproject.org/index.php/jcas/article/view/111

Download Citation

Issue

Vol 3 No 1 (2017): Journal of Cancer & Allied Specialties

Section

Images in Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors retain copyright and grant the Journal of Cancer & Allied Specialties (JCAS) right-of-first publication. In addition, the work will be simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. This license allows others to share the work in whole or part (for non-commercial purpose), with an acknowledgement of the work’s authorship and initial publication in JCAS.

Furthermore, authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to share their work online or in medical or scientific conferences prior to or during submission process.